These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20888330)
1. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Li T; Cao H; Zhuang J; Wan J; Guan M; Yu B; Li X; Zhang W Clin Chim Acta; 2011 Jan; 412(1-2):66-70. PubMed ID: 20888330 [TBL] [Abstract][Full Text] [Related]
2. Altered Plasma MicroRNAs as Novel Biomarkers for Arteriosclerosis Obliterans. He XM; Zheng YQ; Liu SZ; Liu Y; He YZ; Zhou XY J Atheroscler Thromb; 2016; 23(2):196-206. PubMed ID: 26370316 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Wang M; Li W; Chang GQ; Ye CS; Ou JS; Li XX; Liu Y; Cheang TY; Huang XL; Wang SM Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2044-53. PubMed ID: 21817107 [TBL] [Abstract][Full Text] [Related]
4. Circulating miR-130a, miR-27b, and miR-210 in Patients With Peripheral Artery Disease and Their Potential Relationship With Oxidative Stress. Signorelli SS; Volsi GL; Pitruzzella A; Fiore V; Mangiafico M; Vanella L; Parenti R; Rizzo M; Volti GL Angiology; 2016 Nov; 67(10):945-950. PubMed ID: 26980776 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Wang JF; Yu ML; Yu G; Bian JJ; Deng XM; Wan XJ; Zhu KM Biochem Biophys Res Commun; 2010 Mar; 394(1):184-8. PubMed ID: 20188071 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Sukata T; Sumida K; Kushida M; Ogata K; Miyata K; Yabushita S; Uwagawa S Toxicol Lett; 2011 Jan; 200(1-2):46-52. PubMed ID: 21035526 [TBL] [Abstract][Full Text] [Related]
7. Dilation and reduced distensibility of carotid artery in patients with abdominal aortic aneurysms. Makita S; Ohira A; Tachieda R; Itoh S; Moriai Y; Niinuma H; Nakamura M; Hiramori K Am Heart J; 2000 Aug; 140(2):297-302. PubMed ID: 10925346 [TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis obliterans of the lower extremities in Thai patients. Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835 [TBL] [Abstract][Full Text] [Related]
10. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Kawano T; Saito T; Yasu T; Saito T; Nakamura T; Namai K; Tamemoto H; Kawakami M; Saito M; Ishikawa SE Metabolism; 2005 May; 54(5):653-6. PubMed ID: 15877296 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610 [TBL] [Abstract][Full Text] [Related]
12. [Arteriosclerosis obliterans (ASO)]. Koshikawa M; Ikeda U Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Ai J; Zhang R; Li Y; Pu J; Lu Y; Jiao J; Li K; Yu B; Li Z; Wang R; Wang L; Li Q; Wang N; Shan H; Li Z; Yang B Biochem Biophys Res Commun; 2010 Jan; 391(1):73-7. PubMed ID: 19896465 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Ji R; Cheng Y; Yue J; Yang J; Liu X; Chen H; Dean DB; Zhang C Circ Res; 2007 Jun; 100(11):1579-88. PubMed ID: 17478730 [TBL] [Abstract][Full Text] [Related]
15. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Kumarswamy R; Anker SD; Thum T Circ Res; 2010 May; 106(9):e8; author reply e9. PubMed ID: 20466983 [No Abstract] [Full Text] [Related]
19. [Certain biochemical alterations in the blood of patients with atherosclerosis obliterans of the lower limb arteries]. Shval'b NG; Kalinin RE Angiol Sosud Khir; 2007; 13(3):34-7. PubMed ID: 18389577 [TBL] [Abstract][Full Text] [Related]
20. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]